Media coverage
1
Media coverage
Title Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy. Media name/outlet Clinical Trials.gov Country/Territory United States Date 18/10/2 Persons Yongbae Kim